Cargando…

Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis

BACKGROUND/AIMS: In ulcerative colitis (UC) patients, Escherichia coli Nissle 1917 (EcN) is equivalent to mesalazine for preventing disease relapse; however, evidence of the ability of EcN to increase health-related quality of life or induce remission remains scarce. We investigated the efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Soo-Kyung, Kang, Sang-Bum, Kim, SangSoo, Kim, Tae Oh, Cha, Jae Myung, Im, Jong Pil, Choi, Chang Hwan, Kim, Eun Soo, Seo, Geom Seog, Eun, Chang Soo, Han, Dong Soo, Park, Dong Il
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association of Internal Medicine 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449212/ https://www.ncbi.nlm.nih.gov/pubmed/36068716 http://dx.doi.org/10.3904/kjim.2021.458

Ejemplares similares

Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study
por: Park, Soo-Kyung, et al.
Publicado: (2019)

Potential Oral Microbial Markers for Differential Diagnosis of Crohn’s Disease and Ulcerative Colitis Using Machine Learning Models
por: Kang, Sang-Bum, et al.
Publicado: (2023)

Efficacy of sigmoidoscopy for evaluating disease activity in patients with ulcerative colitis
por: Park, Su Bum, et al.
Publicado: (2022)

Is Clostridium difficile infection a real threat in patients with ulcerative colitis? A prospective, multicenter study in Korea
por: Kim, Dae Bum, et al.
Publicado: (2018)

Development of a Machine Learning Model to Distinguish between Ulcerative Colitis and Crohn’s Disease Using RNA Sequencing Data
por: Park, Soo-Kyung, et al.
Publicado: (2021)

Second Korean guidelines for the management of ulcerative colitis
por: Choi, Chang Hwan, et al.
Publicado: (2017)

Recurrent Mesalazine-Induced Myopericarditis in a Patient with Ulcerative Colitis
por: Park, Eun Hye, et al.
Publicado: (2012)

Long-term outcomes of infliximab in a real-world multicenter cohort of patients with acute severe ulcerative colitis
por: Oh, Shin Ju, et al.
Publicado: (2021)

Does the Cyclosporine Still Have a Potential Role in the Treatment of Acute Severe Steroid-Refractory Ulcerative Colitis?
por: Eun, Chang Soo, et al.
Publicado: (2015)

Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis
por: Na, Soo-Young, et al.
Publicado: (2023)

Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?
por: Kim, Eun Soo
Publicado: (2021)

Factors associated with low adherence to oral 5-aminosalicylic acid in patients with ulcerative colitis
por: Lee, Jin, et al.
Publicado: (2019)

Patient Preference and Adherence to Aminosalicylates for the Treatment of Ulcerative Colitis
por: Tripathi, Kartikeya, et al.
Publicado: (2021)

Is the Long-term Disease Course of Elderly-Onset Ulcerative Colitis Different from That of Non-Elderly-Onset Ulcerative Colitis?
por: Lee, Jin Wook, et al.
Publicado: (2021)

Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study
por: Shin, Seung Yong, et al.
Publicado: (2022)

Does Lymphocytic Colitis Always Present with Normal Endoscopic Findings?
por: Park, Hye Sun, et al.
Publicado: (2015)

Changes in fecal metabolic and lipidomic features by anti-TNF treatment and prediction of clinical remission in patients with ulcerative colitis
por: Kim, Seok-Young, et al.
Publicado: (2023)

The Common and Unique Pattern of Microbiome Profiles among Saliva, Tissue, and Stool Samples in Patients with Crohn’s Disease
por: Shin, Seung Yong, et al.
Publicado: (2022)

Risk Factors for Postoperative Recurrence in Korean Patients with Crohn’s Disease
por: Kim, Sung Bae, et al.
Publicado: (2020)

Clinical importance of weight gain and associated factors in patients with moderate to severe ulcerative colitis: results from the MOSAIK cohort in Korea
por: Yoon, Hyuk, et al.
Publicado: (2023)

JAK Inhibitors Safety in Ulcerative Colitis: Practical Implications
por: Agrawal, Manasi, et al.
Publicado: (2020)

Role of innate lymphoid cells in chronic colitis during anti-IL-17A therapy
por: Park, Chan Hyuk, et al.
Publicado: (2020)

5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
por: Miyoshi, Jun, et al.
Publicado: (2018)

Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Multicenter, Prospective, Postmarketing Surveillance Study
por: Yu, Jongwook, et al.
Publicado: (2022)

Comparison of maintenance effect of probiotics and aminosalicylates on ulcerative colitis: A meta-analysis of randomized controlled trials
por: Jiang, Yong, et al.
Publicado: (2016)

Differentially Abundant Bacterial Taxa Associated with Prognostic Variables of Crohn’s Disease: Results from the IMPACT Study
por: Park, Soo-kyung, et al.
Publicado: (2020)

Clinicopathological features of laterally spreading colorectal tumors and their association with advanced histology and invasiveness: An experience from Honam province of South Korea: A Honam Association for the Study of Intestinal Diseases (HASID)
por: Myung, Dae-Seong, et al.
Publicado: (2017)

Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients
por: Ro, Youngouk, et al.
Publicado: (2016)

Modulation of hepatic stellate cells by Mutaflor(®) probiotic in non-alcoholic fatty liver disease management
por: Hany, Noha M., et al.
Publicado: (2022)

Differences in Immunophenotyping of Mucosal Lymphocytes Between Ulcerative Colitis and Crohn’s Disease
por: Lee, Heung Bum, et al.
Publicado: (1997)

Probiotics combined with aminosalicylic acid affiliates remission of ulcerative colitis: a meta-analysis of randomized controlled trial
por: Peng, Lijun, et al.
Publicado: (2019)

Infliximab versus Cyclosporine Treatment for Severe Corticosteroid-Refractory Ulcerative Colitis: A Korean, Retrospective, Single Center Study
por: Kim, Eun Hye, et al.
Publicado: (2015)

Prognostic Value of Terminal Ileal Inflammation in Patients with Ulcerative Colitis
por: Yu, Jongwook, et al.
Publicado: (2021)

Clinicopathological feature and treatment outcome of patients with colorectal laterally spreading tumors treated by endoscopic submucosal dissection
por: Jeong, Young-Hoon, et al.
Publicado: (2019)

Development of a Clinical and Genetic Prediction Model for Early Intestinal Resection in Patients with Crohn’s Disease: Results from the IMPACT Study
por: Kang, Eun Ae, et al.
Publicado: (2021)

Real-life effectiveness and safety of tofacitinib treatment in patients with ulcerative colitis: a KASID multicenter cohort study
por: Shin, Seung Hwan, et al.
Publicado: (2023)

Enrichment of Activated Fibroblasts as a Potential Biomarker for a Non-Durable Response to Anti-Tumor Necrosis Factor Therapy in Patients with Crohn’s Disease
por: Park, Soo-Kyung, et al.
Publicado: (2023)

Colon-targeting mutual prodrugs of 5-aminosalicylic acid and butyrate for the treatment of ulcerative colitis
por: Yan, Yan, et al.
Publicado: (2018)

Risk factors for procedure-related complications after endoscopic resection of colorectal laterally spreading tumors
por: Hong, Ji-Yun, et al.
Publicado: (2018)

Medical Management of Ulcerative Colitis with a Specific Focus on 5-Aminosalicylates
por: Freeman, Hugh James
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5g93oc30ti13aqbnvaql96e0t5